Osong Public Health and Research Perspectives最新文献

{"title":"Points to consider when developing drugs for dry eye syndrome.","authors":"Suyoung Bae,&nbsp;Hosun Seung,&nbsp;Ho Jung Oh","doi":"10.24171/j.phrp.2023.0031","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0031","url":null,"abstract":"<p><p>Changes in both the social environment (e.g., the increased use of electronic media) and the atmospheric environment (e.g., air pollution and dust) have contributed to an increasing incidence of eye disease and an increased need for eye care. Notably, the signs and symptoms of dry eye syndrome can impact the daily quality of life for various age groups, including the elderly, and usually requires active treatment. The symptoms of dry eye syndrome include tear film instability, hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities. As treatments for dry eye are being developed, a standardized guideline is needed to increase the efficiency of drug development and improve the quality of clinical trial data. In this paper, we present general considerations for the pharmaceutical industry and clinical trial investigators designing clinical trials focused on the development of drugs to treat dry eye syndrome.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"70-75"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/53/j-phrp-2023-0031.PMC10211449.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea.","authors":"Chungman Chae,&nbsp;Sangwoo Tak","doi":"10.24171/j.phrp.2022.0321","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0321","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to estimate the impact of the national hepatitis B immunization program on the incidence of acute hepatitis B infection among adolescents in South Korea.</p><p><strong>Methods: </strong>We estimated the counterfactual incidence rate of reported acute hepatitis B among adolescents from 2016 to 2020 compared to the assumption that the national hepatitis B immunization program for children had not been implemented since 1995. The impact of the national hepatitis B immunization program for adolescents was measured by estimating the absolute risk reduction and averted acute hepatitis B infections among adolescents from 2016 to 2020 attributed to the national immunization program.</p><p><strong>Results: </strong>The relative risk reduction of acute hepatitis B among adolescents was estimated to be 83.5% after implementing the national hepatitis B immunization program. The incidence rate of reported acute hepatitis B infections among adolescents decreased from 0.39 to 0.06 per 100,000 person-years, and 43 acute hepatitis B infections, including 17 symptomatic cases, were averted annually from 2016 to 2020 by the national hepatitis B immunization program.</p><p><strong>Conclusion: </strong>The national hepatitis B immunization program for children was effective in preventing acute hepatitis B infection among adolescents in South Korea.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"138-145"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/bf/j-phrp-2022-0321.PMC10211452.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quality of life in patients treated for COVID-19-associated mucormycosis at a tertiary care hospital.","authors":"Pragya Kumar, Rajath Rao Ur, Nilanjan Roy, Deepika Agrawal, Shamshad Ahmad, Kranti Bhavana","doi":"10.24171/j.phrp.2022.0307","DOIUrl":"10.24171/j.phrp.2022.0307","url":null,"abstract":"<p><strong>Objectives: </strong>Coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) has emerged as a formidable infection in patients with COVID-19. The aggressive management of CAM affects quality of life (QOL); thus, this study was designed to assess the QOL in patients with CAM at a tertiary healthcare institution.</p><p><strong>Methods: </strong>This cross-sectional study of 57 patients with CAM was conducted over 6 months using a semi-structured standard questionnaire (the abbreviated World Health Organization Quality of Life questionnaire [WHO-BREF]) and a self-rated improvement (SRI) scale ranging from 0 to 9. Cut-off values of ≤52 and <7 were considered to indicate poor QOL and poor improvement, respectively. The correlations of QOL and SRI scores were evaluated using Spearman rho values.</p><p><strong>Results: </strong>In total, 27 patients (47.4%; 95% confidence interval [CI], 34.9%-60.1%) and 26 patients (45.6%; 95% CI, 33.4%-58.4%) had poor QOL and poor SRI scores, respectively. The overall median (interquartile range) QOL score was 52 (41-63). Headache (adjusted B, -12.3), localized facial puffiness (adjusted B , -16.4), facial discoloration (adjusted B, -23.4), loosening of teeth (adjusted B, -18.7), and facial palsy (adjusted B, -38.5) wer e significantly associated with the QOL score in patients with CAM.</p><p><strong>Conclusion: </strong>Approximately 1 in 2 patients with CAM had poor QOL and poor improvement. Various CAM symptoms were associated with QOL in these patients. Early recognition is the key to optimal treatment, improved outcomes, and improved QOL in patients with CAM.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"119-128"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/fe/j-phrp-2022-0307.PMC10211455.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9896804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vaccine hesitancy in patients with COVID-19 who have back pain.","authors":"Askeri Türken, Haşim Çapar","doi":"10.24171/j.phrp.2023.0003","DOIUrl":"10.24171/j.phrp.2023.0003","url":null,"abstract":"<p><strong>Objectives: </strong>Musculoskeletal pain is among the most common symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19), and it has placed a significant burden on health worldwide during the pandemic. This study explored vaccine hesitancy and associated factors in patients with positive COVID-19 polymerase chain reaction test results who were hospitalized and had back pain.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among 170 hospitalized COVID-19 patients over 18 years of age. Data were analyzed using descriptive statistics with IBM SPSS ver. 25.0.</p><p><strong>Results: </strong>COVID-19 patients who were married considered COVID-19 vaccinations riskier than unmarried COVID-19 patients. Patients who had not been vaccinated expressed higher levels of distrust towards COVID-19 vaccines than patients who had been vaccinated. Participants had relatively little hesitation toward the Sinovac vaccine. High vaccine confidence was found in all participants regardless of vaccination status. Those who had not received the COVID-19 vaccine reported higher risk perceptions than those who had received at least 1 dose of any COVID-19 vaccine.</p><p><strong>Conclusion: </strong>Measurements of the hesitancy of vaccinated and non-vaccinated patients or members of society towards vaccines can be an important parameter for health authorities to find solutions.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"100-109"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/85/92/j-phrp-2023-0003.PMC10211457.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to the comment of Perone by the corresponding author Kim.","authors":"Yongmoon Kim,&nbsp;Bryan Inho Kim,&nbsp;Sangwoo Tak","doi":"10.24171/j.phrp.2023.0072R","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0072R","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"147"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/17/27/j-phrp-2023-0072R.PMC10211451.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk factors for deaths associated with COVID-19 according to the cause of death classification in Republic of Korea.","authors":"Na-Young Kim,&nbsp;Seong-Sun Kim,&nbsp;Hyun Ju Lee,&nbsp;Dong Hwi Kim,&nbsp;Boyeong Ryu,&nbsp;Eunjeong Shin,&nbsp;Donghyok Kwon","doi":"10.24171/j.phrp.2022.0312","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0312","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to classify coronavirus disease 2019 (COVID-19)-related deaths according to whether COVID-19 was listed as the cause of death, and to investigate the differences in demographic characteristics and risk factors for COVID-19 death classifications.</p><p><strong>Methods: </strong>A total of 5,625 deaths in South Korea among patients with confirmed COVID-19 from January 20, 2020 to December 31, 2021 were selected. Excluding false reports and unnatural deaths, 5,597 deaths were analyzed. Based on death report data, deaths were classified according to whether the cause of death was listed as COVID-19 (CD) or not (NCD). The epidemiological characteristics and causes of deaths were investigated using descriptive, univariate, and multivariate statistical analyses. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to analyze the risk factors.</p><p><strong>Results: </strong>The case fatality ratio was 0.89% and increased with age. Additionally, 96.4% of the subjects had an underlying disease, and 53.4% died in winter. The proportion of NCDs was 9.3%, of whom 19.1% died at home and 39.0% were confirmed to have COVID-19 after death. Malignant neoplasms (102/416 vs. 637/4,442; OR, 1.71; 95% CI, 1.36-2.16; p<0.001) were significantly associated with NCD.</p><p><strong>Conclusion: </strong>This is the first study to analyze risk factors by cause of death using COVID-19 death report data in South Korea. These results are expected to be used as evidence for establishing a death monitoring system that can collect timely information in a new infectious disease pandemic.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"89-99"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/96/j-phrp-2022-0312.PMC10211456.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comments on the article \"Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates\".","authors":"Gaetano Perone","doi":"10.24171/j.phrp.2023.0072L","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0072L","url":null,"abstract":"To the Editor: I read the recently published article by Kim et al. [1]. On page 424 [1], the authors state, referring to my paper [2], that “other research using time-series cross-sectional data appears to have underestimated the impact of autocorrelation and heteroscedasticity”. However, this statement is incorrect and unfounded for 2 reasons. First, I used cross-sectional data rather than panel data, so there was no time component. The corollary is that residuals cannot be serially correlated. It makes no sense to consider autocorrelation in this case. Second, as shown in Section 5.1 of Perone [2], I safely considered heteroscedasticity in my paper: “Furthermore, since Breusch and Pagan (1979) and Shapiro and Wilk (1965) tests allowed to accept the null hypothesis of homoscedasticity and normality of residuals, models seemed well specified. However, due to the small sample, I preferred to adopt a conservative approach, by applying the HC2 correction proposed by MacKinnon and White (1985)” [3−5]. As a result, autocorrelation and heteroscedasticity issues have no bearing on the results of my paper. Notes","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"146"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/f9/j-phrp-2023-0072L.PMC10211453.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Early countermeasures to COVID-19 at long-term care facilities in Gwangju Metropolitan City, Republic of Korea.","authors":"Hye-Jin Kim,&nbsp;Jieun Kim,&nbsp;Yoon Suk Jang,&nbsp;Hanul Park,&nbsp;Jong Mu Kim,&nbsp;Young Joon Park,&nbsp;So-Yeon Ryu,&nbsp;Jun Hwi Cho,&nbsp;So Yeong Park,&nbsp;Sang-Eun Lee","doi":"10.24171/j.phrp.2022.0293","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0293","url":null,"abstract":"<p><strong>Objectives: </strong>The coronavirus disease 2019 (COVID-19) pandemic has continued since its first detection in the Republic of Korea on January 20, 2020. This study describes the early countermeasures used to minimize the risk of COVID-19 outbreaks during cohort quarantine and compares the epidemiological characteristics of 2 outbreaks in long-term care facilities (LTCFs) in Gwangju Metropolitan City in summer 2020.</p><p><strong>Methods: </strong>An epidemiological investigation was conducted via direct visits. We investigated epidemiological characteristics, including incidence, morbidity, and mortality rates, for all residents and staff members. Demographic characteristics were analyzed using a statistical program. Additionally, the method of managing infection in LTCFs is described.</p><p><strong>Results: </strong>Residents and caregivers had high incidence rates in LTCF-A and LTCF-B, respectively. LTCF-B had a longer quarantine period than LTCF-A. The attack rate was 20.02% in LTCF-A and 27.9% in LTCF-B. The mortality rate was 2.3% (1/43) in LTCF-B, the only facility in which a COVID-19 death occurred.</p><p><strong>Conclusions: </strong>Extensive management requires contact minimization, which involves testing all contacts to mitigate further transmission in the early stages of LTCF outbreaks. The findings of this study can help inform and prepare public health authorities for COVID-19 outbreaks, particularly for early control in vulnerable facilities.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 1","pages":"59-65"},"PeriodicalIF":4.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/f7/j-phrp-2022-0293.PMC10211439.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How we will reach a safer community.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2023.0057","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0057","url":null,"abstract":"At the end of last year, the Republic of Korea, China, and Japan responded to concerns about the increase in new coronavirus disease 2019 (COVID-19) patients and the emergence of new variants by strengthening their surveillance and quarantine measures. However, contrary to these concerns, the number of new cases and deaths decreased globally, and some have expressed the opinion that the World Health Organization (WHO) should reevaluate the declaration of a global public health crisis. However, the decision has been made to maintain the crisis status for the time being [1]. Nevertheless, in the first week of January, when the Rt value dropped below 1, the Republic of Korea implemented an exit strategy and has enforced it since January 30 [2]. The use of masks in public health facilities where a large number of people gather is now at individuals’ discretion, while their use is mandatory in public transportation. And, it is necessary to transition to a long-term strategy based on the endemicity of COVID-19. In the United States, the BXX. 1.5 variant has become predominant, but it is expected to be resolved by May 11th [3]. Therefore, the search for an exit strategy should consider which measures should be prioritized to prepare for the next pandemic. Building public trust in the safety and efficacy of currently available COVID-19 vaccines is of the utmost importance. Nationwide vaccination and booster programs have been initiated to curb the ongoing pandemic. During the vaccination campaign over the past 3 years, reports of vaccine adverse events have led to the need for research on the epidemiological relationship between vaccination and serious illnesses. To ensure scientific and objective judgments regarding this issue, the government has entrusted research on the adverse effects of COVID-19 vaccinations to the National Academy of Medicine of Korea. The study by Jeong et al. [4] published in this issue summarizes the methods used to research important adverse events following immunization; the ultimate goal of this research program is to increase the reliability of vaccines and combat vaccine hesitancy among medical professionals and the public. The second measure that must be prioritized is the improvement of governance by amending laws and regulations related to infectious diseases. After the Middle East respiratory syndrome outbreak in 2015, the government introduced a legal system that classifies reporting and quarantine methods for disease management based on the severity of each disease group. However, the severity of COVID-19 can change depending on vaccination or mutations in the virus. Thus, the government has changed the classification of COVID-19 from a level 1 disease, which requires immediate reporting, isolation, and treatment cost support, to a level 4 disease, which requires self-payment of treatment and surveillance. This adjustment of the severity level has created confusion in its management and procedural problems related to ","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 1","pages":"1-4"},"PeriodicalIF":4.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/fa/j-phrp-2023-0057.PMC10211445.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The first reported hepatitis E outbreak in a food manufacturing factory: Korea, 2022.","authors":"Hansol Yeom,&nbsp;Soonryu Seo,&nbsp;Youngsil Yoon,&nbsp;Jaeeun Lee,&nbsp;Myung-Guk Han,&nbsp;Deog-Yong Lee,&nbsp;Sun-Whan Park,&nbsp;Song A Park,&nbsp;Sook-Hyang Jeong,&nbsp;Jin Gwack","doi":"10.24171/j.phrp.2022.0305","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0305","url":null,"abstract":"<p><strong>Objectives: </strong>On February 16, 2022, 12 cases of hepatitis E virus (HEV) infection were reported in a food manufacturing factory in Korea. The aim of this study was to identify additional cases and to determine the source of this HEV outbreak.</p><p><strong>Methods: </strong>This study was an in-depth investigation of 12 HEV immunoglobulin M (IgM)-positive cases and their demographic, clinical, and epidemiological characteristics. On-site specimens were collected from the environment and from humans, and a follow-up investigation was conducted 2 to 3 months after the outbreak.</p><p><strong>Results: </strong>Among 80 production workers in the factory, 12 (15.0%) had acute HEV infection, all of whom were asymptomatic. The follow-up investigation showed that 3 cases were HEV IgMpositive, while 6 were HEV IgG-positive. HEV genes were not detected in the HEV IgM-positive specimens. HEV genes were not detected in the food products or environmental specimens collected on-site. HEV was presumed to be the causative pathogen. However, it could not be confirmed that the source of infection was common consumption inside the factory.</p><p><strong>Conclusions: </strong>This was the first domestic case of an HEV infection outbreak in a food manufacturing factory in Korea. Our results provide information for the future control of outbreaks and for the preparation of measures to prevent domestic outbreaks of HEV infection.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 1","pages":"15-22"},"PeriodicalIF":4.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/72/j-phrp-2022-0305.PMC10211441.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}